TYSABRI
Dead / Cancelled — Cancelled — Section 8 (as of 07 Feb 2014)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 78978233
- Registration number
- 3259576
- Mark type
- Design + words
- Filed
- 19 Nov 2004
- Published for opposition
- 08 Nov 2005
- Registered
- 03 Jul 2007
- Attorney of record
- Raymond I. Geraldson, Jr.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of inflammatory disorders, diseases and conditions, and for the treatment of physiological conditions relating to cell adhesion, signaling and migration
Owner
- Elan Pharmaceuticals, Inc., South San Francisco, CA, US
- Elan Pharmaceuticals, Inc., South San Francisco, CA, US
- Elan Pharmaceuticals, Inc., South San Francisco, CA, US
Prior registrations
Prosecution history
- 07 Feb 2014 — CANCELLED SEC. 8 (6-YR)
- 10 Apr 2013 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 03 Jul 2007 — REGISTERED-PRINCIPAL REGISTER
- 19 Apr 2007 — LAW OFFICE REGISTRATION REVIEW COMPLETED
- 19 Apr 2007 — ASSIGNED TO LIE
- 29 Mar 2007 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 10 Mar 2007 — NOTICE OF DESIGN SEARCH CODE MAILED
- 09 Mar 2007 — STATEMENT OF USE PROCESSING COMPLETE
- 30 Jan 2007 — USE AMENDMENT FILED
- 09 Mar 2007 — DIVISIONAL PROCESSING COMPLETE
- 01 Feb 2007 — DIVISIONAL REQUEST RECEIVED
- 01 Feb 2007 — PAPER RECEIVED
- 30 Jan 2007 — SOU TEAS EXTENSION RECEIVED
- 30 Jan 2007 — TEAS STATEMENT OF USE RECEIVED
- 15 Sept 2006 — SOU EXTENSION 1 GRANTED